Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions
2007

Effects of Anti-Hyperglycemic Agents on Blood Vessel Cells

Sample size: 5 publication 10 minutes Evidence: moderate

Author Information

Author(s): Peter J Little, Narin Osman, Stephanie T de Dios, Nelly Cemerlang, Mandy Ballinger, Julie Nigro

Primary Institution: Monash University, Faculty of Medicine, Nursing and Health Sciences

Hypothesis

Do oral anti-hyperglycemic agents inhibit vascular smooth muscle cell proliferation under varying glucose conditions?

Conclusion

Thiazolidinediones (TZDs) effectively inhibit vascular smooth muscle cell proliferation, especially under high glucose conditions, while other classes of anti-hyperglycemic agents do not.

Supporting Evidence

  • TZDs showed greater inhibitory activity under high glucose conditions.
  • Troglitazone increased [3H]-thymidine incorporation at low concentrations but inhibited at high concentrations.
  • Metformin had no effect on cell proliferation, while phenformin showed inhibitory effects.

Takeaway

Some diabetes medications can help stop certain cells in blood vessels from growing too much, which is important for heart health.

Methodology

Vascular smooth muscle cell proliferation was assessed using [3H]-thymidine incorporation and cell counting, with glucose concentration variations.

Potential Biases

Potential conflicts of interest due to funding from pharmaceutical companies.

Limitations

The study primarily focused on in vitro conditions, which may not fully represent in vivo effects.

Participant Demographics

Human vascular smooth muscle cells isolated from patients undergoing surgery.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1475-2840-6-33

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication